Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001062993-25-010155
Filing Date
2025-05-23
Accepted
2025-05-23 09:04:08
Documents
1
Period of Report
2025-05-21

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 4778
  Complete submission text file 0001062993-25-010155.txt   6430
Mailing Address C/O RXI PHARMACEUTICALS CORPORATION 1500 WEST PARK DRIVE, SUITE 210 WESTBOROUGH MA 01581
Business Address
Bitterman Robert J (Reporting) CIK: 0001304395 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36304 | Film No.: 25979457

Mailing Address 11 APEX DRIVE, SUITE 300A PMB 2006 MARLBOROUGH MA 01752
Business Address 11 APEX DRIVE, SUITE 300A PMB 2006 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Issuer) CIK: 0001533040 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)